Spain – Various medicinal products – Suministro del medicamento Polivy (Principio activo Polatuzumab 30 mg vial perf IV)
Dirección Gerente del Hospital Universitario Nuestra Señora de Candelaria awarded €472K to Roche Farma SA for Construction & Public Works in June 2024 — one of 94 awards this buyer has made, above its typical award size.
Winning supplier
Roche Farma SAContract description
Spain – Various medicinal products – Suministro del medicamento Polivy (Principio activo Polatuzumab 30 mg vial perf IV) de cuantia indeterminada (Disposición adicional 33 de la Ley 9/2017 de Contratos del Sector Público, mediante procedimiento negociado sin publicidad y tramitación ordinaria, con destino el servicio de Farmacia del Hospital Universitario Nuestra Señora de Candelaria, a realizar p
Related awards · Dirección Gerente del Hospital Universitario Nuestra Señora de Candelaria
94 awardsThe buyer's full award list ranked by value, with the winning supplier, date and sector on every row — plus CSV / API export.
- ocds-ted-354025-2025WERFEN ESPAÑA, S.A.U.€652K02 Jun 2025 Construction
- ocds-ted-696051-2024KERN PHARMA, S.L.€561K15 Nov 2024 Construction
- ocds-ted-693178-2024Roche Farma, S.A.€553K14 Nov 2024 Construction
Other wins · Roche Farma SA
26 winsThe supplier's complete win history across every buyer it sells to — not just the handful shown here.
- ocds-ted-51673-2026Fundación de Gestión Sanitaria del Hospital de la Santa Creu i Sant Pau€58.3M23 Jan 2026 Construction
- ocds-ted-149649-2026-7Servicio Andaluz de Salud. Hospital Universitario Puerta del Mar€3.6M04 Mar 2026 Construction
- ocds-ted-673514-2024-1Servicio de Salud - Servicios Centrales€3.4M05 Nov 2024 Construction
Premium · full dataset
See the full award context.
Competing bids, award margins and every related contract for Dirección Gerente del Hospital Universitario Nuestra Señora de Candelaria and Roche Farma SA — one subscription unlocks everything.
Sign Up Free →Free account · cancel anytime · 14-day money-back